Atlas Trials

Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia

Clinical trial NCT00004052 · COMPLETED

Trial details

NCT number
NCT00004052
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
1999-03-01
Primary completion
2005-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.